Page last updated: 2024-08-21

paraquat and lgk974

paraquat has been researched along with lgk974 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, JJ; Chiou, CT; Huang, CL; Huang, HM; Huang, HT; Huang, NK; Lee, YC; Yang, JM; Yang, YC	1

Other Studies

1 other study(ies) available for paraquat and lgk974

Article	Year
LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway. Toxicology, 2018, 12-01, Volume: 410 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Cell Line; Cell Line, Tumor; Cell Survival; Glycogen Synthase Kinase 3; Humans; Immunohistochemistry; Paraquat; Parkinson Disease; Pyrazines; Pyridines; Wnt Signaling Pathway	2018

Article

Year

LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway.

Toxicology, 2018, 12-01, Volume: 410

Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Cell Line; Cell Line, Tumor; Cell Survival; Glycogen Synthase Kinase 3; Humans; Immunohistochemistry; Paraquat; Parkinson Disease; Pyrazines; Pyridines; Wnt Signaling Pathway

2018